Advertisement

Asthma and Allergy in Childhood: Prediction and Early Diagnosis

  • Karin C Lødrup Carlsen
  • Göran Wennergren
Part of the Allergy Frontiers book series (ALLERGY, volume 5)

Clinicians would be at a great advantage if they at an early stage could identify the children who would develop asthma or other allergic disease in the future and who would remain or become healthy in later childhood and adult life. Then, resources could be focused more towards those with likely persistent disease to ensure optimal relevant management. For the scientists, identifying children who will go on to develop a disease, could provide a strong basis for understanding disease development as well as for giving appropriate advice to the community on how to prevent or diminish the potential harmful influences whenever possible.

Parents need to know at the earliest possible stage whether or not their coughing or wheezing child is starting a life long career in allergic diseases, or if the symptoms are passing with a healthy outcome. Thus, appropriate early management, primary or secondary prevention, and prognosis estimates, all point to the necessity or value of trying to predict any disease.

Keywords

Lung Function Atopic Eczema Food Allergy Allergic Rhinitis Allergic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. John Wiley and Sons, New York, 2000.Google Scholar
  2. 2.
    Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ 1999; 319: 1562–1565.PubMedGoogle Scholar
  3. 3.
    Croner S. Prediction and detection of allergy development: influence of genetic and environmental factors. J Pediatr 1992; 121: S58–S63.CrossRefPubMedGoogle Scholar
  4. 4.
    Christie GL, McDougall CM, Helms PJ. Is the increase in asthma prevalence occurring in children without a family history of atopy? Scott Med J 1998; 43: 180–182.PubMedGoogle Scholar
  5. 5.
    Burke W, Fesinmeyer M, Reed K, Hampson L, Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med 2003; 24: 160–169.CrossRefPubMedGoogle Scholar
  6. 6.
    Gold DR. Environmental tobacco smoke, indoor allergens, and childhood asthma. Environ Health Perspect 2000; 108 Suppl 4: 643–651.CrossRefPubMedGoogle Scholar
  7. 7.
    Bornehag CG, Sundell J, Sigsgaard T. Dampness in buildings and health (DBH): Report from an ongoing epidemiological investigation on the association between indoor environmental factors and health effects among children in Sweden. Indoor Air 2004; 14 Suppl 7: 59–66.CrossRefPubMedGoogle Scholar
  8. 8.
    Loftus BG, Price JF. Clinical and immunological characteristics of pre-school asthma. Clin Allergy 1986; 16: 251–257.CrossRefPubMedGoogle Scholar
  9. 9.
    Høst A. Frequency of cow's milk allergy in childhood. Ann Allergy Asthma Immunol 2002; 89 Suppl 1: 33–37.PubMedGoogle Scholar
  10. 10.
    Devulapalli CS, Carlsen KC, Håland G, Munthe-Kaas MC, Pettersen M, Mowinckel P, et al. Severity of obstructive airways disease by two years predicts asthma at 10 years of age. Thorax 2008; 63: 8–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Almqvist C, Worm M, Leynaert B. Impact of gender on asthma in childhood and adolescence: a GA(2)LEN review. Allergy 2008; 63: 47–57.PubMedGoogle Scholar
  12. 12.
    Aas K. Heterogeneity of childhood asthma. Allergy 1981; 36: 3–14.CrossRefPubMedGoogle Scholar
  13. 13.
    Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995; 95: 1179–1190.CrossRefPubMedGoogle Scholar
  14. 14.
    Jenkins MA, Hopper JL, Bowes G, Carlin JB, Flander LB, Giles GG. Factors in childhood as predictors of asthma in adult life. BMJ 1994; 309: 90–93.PubMedGoogle Scholar
  15. 15.
    Kjellman NI. IgE in neonates is not suitable for general allergy risk screening. Pediatr Allergy Immunol 1994; 5: 1–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001; 107: 891–896.CrossRefPubMedGoogle Scholar
  17. 17.
    Kulig M, Bergmann R, Niggemann B, Burow G, Wahn U. Prediction of sensitization to inhalant allergens in childhood: evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study. Clin Exp Allergy 1998; 28: 1397–1403.CrossRefPubMedGoogle Scholar
  18. 18.
    Kotaniemi-Syrjänen A, Reijonen TM, Romppanen J, Korhonen K, Savolainen K, Korppi M. Allergen-specific immunoglobulin E antibodies in wheezing infants: the risk for asthma in later childhood. Pediatrics 2003; 111: e255–e261.CrossRefPubMedGoogle Scholar
  19. 19.
    Perkin MR, Strachan DP, Hc W, Lack G, Golding J. The predictive value of early life total immunoglobulin E measurement in identifying atopic children in a population-based birth cohort study. Pediatr Allergy Immunol 2006; 17: 118–124.CrossRefPubMedGoogle Scholar
  20. 20.
    Odelram H, Björkstén B, Leander E, Kjellman NI. Predictors of atopy in newborn babies. Allergy 1995; 50: 585–592.CrossRefPubMedGoogle Scholar
  21. 21.
    Villa JR, Garcia G, Rueda S, Nogales A. Serum eosinophilic cationic protein may predict clinical course of wheezing in young children. Arch Dis Child 1998; 78: 448–452.CrossRefPubMedGoogle Scholar
  22. 22.
    Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403–1406.PubMedGoogle Scholar
  23. 23.
    Hjalte K, Croner S, Kjellman NI. Cost-effectiveness of neonatal IgE-screening for atopic allergy before 7 years of age. Allergy 1987; 42: 97–103.CrossRefPubMedGoogle Scholar
  24. 24.
    Cantani A, Micera M. Natural history of cow's milk allergy. An eight-year follow-up study in 115 atopic children. Eur Rev Med Pharmacol Sci 2004; 8: 153–164.PubMedGoogle Scholar
  25. 25.
    Eysink PE, ter Riet G, Aalberse RC, van Aalderen WM, Roos CM, Van Der Zee JS, et al. Accuracy of specific IgE in the prediction of asthma: development of a scoring formula for general practice. Br J Gen Pract 2005; 55: 125–131.PubMedGoogle Scholar
  26. 26.
    Meyers DA, Freidhoff LR, Marsh DG. Predicting skin test sensitivity and total serum IgE levels in family members. J Allergy Clin Immunol 1986; 77: 608–615.CrossRefPubMedGoogle Scholar
  27. 27.
    Wickman M, Ahlstedt S, Lilja G, van Hage HM. Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year-old children. A report from the prospective birth cohort study--BAMSE. Pediatr Allergy Immunol 2003; 14: 441–447.CrossRefPubMedGoogle Scholar
  28. 28.
    Lilja G, Öman H, Johansson SG. Development of atopic disease during childhood and its prediction by Phadiatop Paediatric. Clin Exp Allergy 1996; 26: 1073–1079.CrossRefPubMedGoogle Scholar
  29. 29.
    Øymar K, Bjerknes R. Is serum eosinophil cationic protein in bronchiolitis a predictor of asthma? Pediatr Allergy Immunol 1998; 9: 204–207.CrossRefPubMedGoogle Scholar
  30. 30.
    Okano M, Nishizaki K, Nakada M, Kawarai Y, Goto S, Satoskar AR, et al. Prevalence and prediction of allergic rhinitis using questionnaire and nasal smear examination in schoolchildren. Acta Otolaryngol Suppl 1999; 540:58–63.PubMedGoogle Scholar
  31. 31.
    Øymar K. High levels of urinary eosinophil protein X in young asthmatic children predict persistent atopic asthma. Pediatr Allergy Immunol 2001; 12: 312–317.CrossRefPubMedGoogle Scholar
  32. 32.
    Pohunek P, Kucera P, Sukova B, Votava F, Zikan J. Serum ECP taken in the acute episode of bronchial obstruction can predict the development of bronchial asthma in young children. Allergy Asthma Proc 2001; 22: 75–79.CrossRefPubMedGoogle Scholar
  33. 33.
    Bahceciler NN, Barlan IB, Nuhoglu Y, Basaran MM. Which factors predict success after discontinuation of inhaled budesonide therapy in children with asthma? J Asthma 2002; 39: 37–46.CrossRefPubMedGoogle Scholar
  34. 34.
    Kim CK, Kim JT, Kang H, Yoo Y, Koh YY. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Allergy 2003; 33: 1409–1414.CrossRefPubMedGoogle Scholar
  35. 35.
    Lex C, Ferreira F, Zacharasiewicz A, Nicholson AG, Haslam PL, Wilson NM, et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 2006; 174: 1286–1291.CrossRefPubMedGoogle Scholar
  36. 36.
    Sekerel BE, Civelek E, Karabulut E, Yildirim S, Tuncer A, Adalioglu G. Are risk factors of childhood asthma predicting disease persistence in early adulthood different in the developing world? Allergy 2006; 61: 869–877.CrossRefPubMedGoogle Scholar
  37. 37.
    Piippo-Savolainen E, Remes S, Korppi M. Does blood eosinophilia in wheezing infants predict later asthma? A prospective 18–20-year follow-up. Allergy Asthma Proc 2007; 28: 163–169.CrossRefPubMedGoogle Scholar
  38. 38.
    Lex C, Jenkins G, Wilson NM, Zacharasiewicz A, Erin E, Hansel TT, et al. Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma? Pediatr Pulmonol 2007; 42: 298–303.CrossRefPubMedGoogle Scholar
  39. 39.
    Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Thorax 1995; 50: 1067–1072.CrossRefPubMedGoogle Scholar
  40. 40.
    Borres MP, Einarsson R, Björkstén B. Serum levels of interleukin-4, soluble CD23 and IFN gamma in relation to the development of allergic disease during the first 18 months of life. Clin Exp Allergy 1995; 25: 543–548.CrossRefPubMedGoogle Scholar
  41. 41.
    Kondo N, Kobayashi Y, Shinoda S, Takenaka R, Teramoto T, Kaneko H, et al. Reduced inter-feron gamma production by antigen-stimulated cord blood mononuclear cells is a risk factor of allergic disorders--6-year follow-up study. Clin Exp Allergy 1998; 28: 1340–1344.CrossRefPubMedGoogle Scholar
  42. 42.
    Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004; 169: 70–76.CrossRefPubMedGoogle Scholar
  43. 43.
    Keil T, Kulig M, Simpson A, Custovic A, Wickman M, Kull I, et al. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures--a GA2LEN initiative. Allergy 2006; 61: 1104–1111.CrossRefPubMedGoogle Scholar
  44. 44.
    Keil T, Kulig M, Simpson A, Custovic A, Wickman M, Kull I, et al. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs -- a GALEN initiative. Allergy 2006; 61: 221–228.CrossRefPubMedGoogle Scholar
  45. 45.
    Kagamimori S, Naruse Y, Kakiuchi H, Yamagami T, Sokejima S, Matsubara I, et al. Does an allergy skin test on school-children predict respiratory symptoms in adulthood? Clin Exp Allergy 1996; 26: 262–269.CrossRefPubMedGoogle Scholar
  46. 46.
    Sampson HA, Scanlon SM. Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr 1989; 115: 23–27.CrossRefPubMedGoogle Scholar
  47. 47.
    Lødrup Carlsen KC, Granum B. Soluble CD14: role in atopic disease and recurrent infections, including otitis media. Curr Allergy Asthma Rep 2007; 7: 436–443.CrossRefGoogle Scholar
  48. 48.
    Spergel JM, Beausoleil JL, Pawlowski NA. Resolution of childhood peanut allergy. Ann Allergy Asthma Immunol 2000; 85: 473–476.PubMedCrossRefGoogle Scholar
  49. 49.
    Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925–931.CrossRefPubMedGoogle Scholar
  50. 50.
    Bergmann RL, Edenharter G, Bergmann KE, Forster J, Bauer CP, Wahn V, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998; 28: 965–970.CrossRefPubMedGoogle Scholar
  51. 51.
    Wennergren G, Åmark M, Åmark K, Óskarsdóttir S, Sten G, Redfors S. Wheezing bronchitis reinvestigated at the age of 10 years. Acta Paediatr 1997; 86: 351–355.CrossRefPubMedGoogle Scholar
  52. 52.
    Hyvärinen MK, Kotaniemi-Syrjänen A, Reijonen TM, Korhonen K, Korppi MO. Teenage asthma after severe early childhood wheezing: an 11 year prospective follow-up. Pediatr Pulmonol 2005; 40: 316–323.CrossRefPubMedGoogle Scholar
  53. 53.
    Piippo-Savolainen E, Remes S, Kannisto S, Korhonen K, Korppi M. Asthma and lung function 20 years after wheezing in infancy: results from a prospective follow-up study. Arch Pediatr Adolesc Med 2004; 158: 1070–1076.CrossRefPubMedGoogle Scholar
  54. 54.
    Goksör E, Åmark M, Alm B, Gustafsson PM, Wennergren G. Asthma symptoms in early childhood — what happens then? Acta Paediatr 2006; 95: 471–478.CrossRefPubMedGoogle Scholar
  55. 55.
    Goksör E, Åmark M, Alm B, Gustafsson PM, Wennergren G. The impact of pre- and postnatal smoke exposure on future asthma and bronchial hyper-responsiveness. Acta Paediatr 2007; 96: 1030–1035.CrossRefPubMedGoogle Scholar
  56. 56.
    Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370: 758–764.CrossRefPubMedGoogle Scholar
  57. 57.
    Turner SW, Palmer LJ, Rye PJ, Gibson NA, Judge PK, Young S, et al. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. Am J Respir Crit Care Med 2002; 165: 1294–1298.CrossRefPubMedGoogle Scholar
  58. 58.
    Håland G, Carlsen KC, Sandvik L, Devulapalli CS, Munthe-Kaas MC, Pettersen M, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355: 1682–1689.CrossRefPubMedGoogle Scholar
  59. 59.
    Young S, Arnott J, Le Souef PN, Landau LI. Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma. J Pediatr 1994; 124: 681–688.CrossRefPubMedGoogle Scholar
  60. 60.
    Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133–138.CrossRefPubMedGoogle Scholar
  61. 61.
    Wildhaber JH, Dore ND, Devadason SG, Hall GL, Hamacher J, Arheden L, et al. Comparison of subjective and objective measures in recurrently wheezy infants. Respiration 2002; 69: 397–405.CrossRefPubMedGoogle Scholar
  62. 62.
    Lødrup Carlsen KC, Magnus P, Carlsen KH. Lung function by tidal breathing in awake healthy newborn infants. Eur Respir J 1994; 7: 1660–1668.CrossRefGoogle Scholar
  63. 63.
    Dezateux C, Fletcher ME, Dundas I, Stocks J. Infant respiratory function after RSV-proven bronchiolitis. Am J Respir Crit Care Med 1997; 155: 1349–1355.PubMedGoogle Scholar
  64. 64.
    Lødrup Carlsen KC, Carlsen KH, Nafstad P, Bakketeig L. Perinatal risk factors for recurrent wheeze in early life. Pediatr Allergy Immunol 1999; 10: 89–95.CrossRefGoogle Scholar
  65. 65.
    Clarke JR, Salmon B, Silverman M. Bronchial responsiveness in the neonatal period as a risk factor for wheezing in infancy. Am J Respir Crit Care Med 1995; 15: 1434–1440.Google Scholar
  66. 66.
    Young S, O'Keeffe PT, Arnott J, Landau LI. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child 1995; 72: 16–24.CrossRefPubMedGoogle Scholar
  67. 67.
    Young S, Arnott J, O'Keeffe PT, Le Souef PN, Landau LI. The association between early life lung function and wheezing during the first 2 years of life. Eur Respir J 2000; 15: 151–157.CrossRefPubMedGoogle Scholar
  68. 68.
    Murray CS, Pipis SD, McArdle EC, Lowe LA, Custovic A, Woodcock A. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population. Thorax 2002; 57: 388–392.CrossRefPubMedGoogle Scholar
  69. 69.
    Håland G, Carlsen KH, Devulapalli CS, Pettersen M, Mowinckel P, Lødrup Carlsen KC. Lung function development in the first 2 years of life is independent of allergic diseases by 2 years. Pediatr Allergy Immunol 2007; 18: 528–534.CrossRefPubMedGoogle Scholar
  70. 70.
    Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 2004; 114: 1282–1287.CrossRefPubMedGoogle Scholar
  71. 71.
    Piippo-Savolainen E, Remes S, Kannisto S, Korhonen K, Korppi M. Early predictors for adult asthma and lung function abnormalities in infants hospitalized for bronchiolitis: a prospective 18- to 20-year follow-up. Allergy Asthma Proc 2006; 27: 341–349.CrossRefPubMedGoogle Scholar
  72. 72.
    Clough JB, Keeping KA, Edwards LC, Freeman WM, Warner JA, Warner JO. Can we predict which wheezy infants will continue to wheeze? Am J Respir Crit Care Med 1999; 160: 1473–1480.PubMedGoogle Scholar
  73. 73.
    Guillet G, Guillet MH. Natural history of sensitizations in atopic dermatitis. A 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms. Arch Dermatol 1992; 128: 187–192.CrossRefPubMedGoogle Scholar
  74. 74.
    Kjellman NI. Natural course of asthma and allergy in childhood. Pediatr Allergy Immunol 1994; 5 (6 Suppl): 13–18.CrossRefPubMedGoogle Scholar
  75. 75.
    Amdekar YK. Natural history of asthma in children. Indian J Pediatr 2001; 68 Suppl 4: S3–S6.PubMedGoogle Scholar
  76. 76.
    Landau LI. Definitions and early natural history. Med J Aust 2002; 177 Suppl: S38–S39.PubMedGoogle Scholar
  77. 77.
    Wood RA. The natural history of food allergy. Pediatrics 2003; 111: 1631–1637.PubMedGoogle Scholar
  78. 78.
    Koh MS, Irving LB. The natural history of asthma from childhood to adulthood. Int J Clin Pract 2007; 61: 1371–1374.CrossRefPubMedGoogle Scholar
  79. 79.
    Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88:373–378.CrossRefPubMedGoogle Scholar
  80. 80.
    The Childhood Asthma Management Program Research Group. Long-term effects of budes-onide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054–1063.CrossRefGoogle Scholar
  81. 81.
    Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985–1997.CrossRefPubMedGoogle Scholar
  82. 82.
    Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A; IFWIN study team. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368:Google Scholar
  83. 83.
    Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corti-costeroids in infants with episodic wheezing. N Engl J Med 2006; 354: 1998–2005.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Karin C Lødrup Carlsen
    • 1
    • 2
  • Göran Wennergren
    • 3
  1. 1.Department of Paediatrics, Division of Woman and ChildOslo University Hospital, Ullevål University HospitalOsloNorway
  2. 2.The Faculty of MedicineUniversity of OsloOsloNorway
  3. 3.Department of PaediatricsGöteborg University, Queen Silvia Children's HospitalGöteborgSweden

Personalised recommendations